Trial intelligence / Profile preview

Randomised double-blind cross-over trial of a novel formoterol DPI vs Oxis Turbohaler in stable persistent asthma

2006-001141-34Phase 3Completed

Sponsor
LABOpoint
Start
Apr 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of formoterol in asthma (2 arms), sponsored by LABOpoint. Started Apr 2006; status: completed.

02

Drugs

formoterol
03

Conditions

asthma

Beyond the preview

Go deeper on 2006-001141-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001141-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call